Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07002034 · ClinicalTrials.gov registry record · Phase 2
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
A Phase 2 study of Adjustment Disorder, sponsored by Reunion Neuroscience.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 20
- Study locations
NCT07002034 is a Phase 2 study of Adjustment Disorder that is actively recruiting participants, run by Reunion Neuroscience. The registered enrollment target is 100 participants. The trial reports 20 study locations across 17 states.
The verdict
NCT07002034, a Phase 2 study of Adjustment Disorder, is actively recruiting participants, sponsored by Reunion Neuroscience.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.
Conditions Studied
Interventions
- DRUG RE104 for Injection
Study Locations (20)
California
- Kadima Neuropsychiatry Institute - San Diego
- Providence Medical Foundation - Santa Rosa
Maryland
- Sunstone Therapies, PC - Rockville
- Sheppard Pratt - Towson
Ohio
- Cleveland Clinic - Cleveland
- The Ohio State University, Department of Psychiatry - Columbus
Alabama
- UAB, Psychiatry and Behavioral Neurology - Birmingham
Arizona
- University of Arizona - Tucson
Colorado
- University of Colorado - Aurora
Florida
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience - Tampa
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07002034
The ClinicalTrials.gov registry entry for NCT07002034 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reunion Neuroscience, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adjustment Disorder appearing as the primary indexed condition, and to 1 intervention - of which RE104 for Injection is the first listed.
NCT07002034 reports 20 study locations spanning 17 distinct geographic areas - top geographies include California, Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT07002034 about?
NCT07002034 is a clinical study titled "RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses". The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multi...
What is the current status of trial NCT07002034?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2025-07-30. Estimated completion is 2026-12.
What conditions does trial NCT07002034 study?
This clinical trial studies the following conditions: Adjustment Disorder.
What interventions are being tested in trial NCT07002034?
The interventions under investigation include: RE104 for Injection (DRUG).
Who is sponsoring clinical trial NCT07002034?
This trial is sponsored by Reunion Neuroscience, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07002034 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adjustment Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.